[ Price : $8.95]
FDA accepts for review an Outlook Therapeutics BLA resubmission for ONS-5010 (bevacizumab-vikg), an investigational ophthalmic for...[ Price : $8.95]
The Government Accountability Office says HHS should have some mechanism in place to coordinate the activities of various HHS agen...[ Price : $8.95]
FDA approves updated labeling for Idorsias blood pressure drug Tryvio after approving the elimination of a REMS requirement.[ Price : $8.95]
Members of Congress from Maryland, led by Rep. Jamie Raskin, ask to meet with FDA commissioner Martin Makary to discuss their conc...[ Price : $8.95]
Former FDA commissioner David Kessler tells a House hearing that recent FDA staff cuts will adversely affect the U.S.s public heal...[ Price : $8.95]
The Minneapolis Star Tribune says medical device companies are concerned that FDA layoffs have resulted in fewer device approvals ...[ Price : $8.95]
ZyVersa Therapeutics says a new regulatory development could significantly shorten the path to approval for treatments targeting f...[ Price : $8.95]
Three former FDAers warn of a slow-moving catastrophe coming for the agency as it loses staff and resources under leaders who have...